4.62
6.70%
0.29
Handel nachbörslich:
4.55
-0.07
-1.52%
Clarivate Plc Aktie (CLVT) Neueste Nachrichten
How to unlock the value in your intellectual property portfolio - Clarivate
Measuring what mattersIntroducing a responsible framework for evaluating the societal impact of research - Clarivate
Clarkston Capital Partners LLC Sells 1,407,380 Shares of Clarivate Plc (NYSE:CLVT) - MarketBeat
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence - Barchart
China's Biopharma Surge: R&D Spending Jumps 3.5x in Decade, Clarivate Report Shows | CLVT Stock News - StockTitan
Short Interest in Clarivate Plc (NYSE:CLVT) Expands By 9.5% - MarketBeat
Clarivate (NYSE:CLVT) Hits New 1-Year LowWhat's Next? - MarketBeat
CLVT (Clarivate) Cash Flow from Financing : $-405 Mil (TTM As of Sep. 2024) - GuruFocus.com
Clarivate's SWOT analysis: stock faces headwinds amid CEO transition By Investing.com - Investing.com Australia
The Truth About Trademark Data: Five Common Myths debunked - Clarivate
Clarivate's SWOT analysis: stock faces headwinds amid CEO transition - Investing.com
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners - AAPNews Logo
Clarivate Publishes 2023 Sustainability Report - AAPNews Logo
Trophy presented to NEC’s Nishihara CTO in recognition of Clarivate - NEC Global
Clarivate Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Clarivate Publishes 2023 Sustainability Report – Company Announcement - Financial Times
Should You Think About Buying Clarivate Plc (NYSE:CLVT) Now? - Yahoo Finance
Clarivate (NYSE:CLVT) Releases Quarterly Earnings Results, Meets Estimates - MarketBeat
Clarivate Plc (NYSE:CLVT) Q3 2024 Earnings Call Transcript - Insider Monkey
Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover - Seeking Alpha
Clarivate launches sustainability research solution - Research Information
Clarivate Launches New Sustainability Research Solution - AAPNews Logo
Clarivate price target lowered to $4 from $5 at Barclays - TipRanks
Clarivate (NYSE:CLVT) Price Target Cut to $4.00 by Analysts at Barclays - MarketBeat
Some Confidence Is Lacking In Clarivate Plc (NYSE:CLVT) As Shares Slide 26% - Simply Wall St
Clarivate Faces Revenue Decline Amid Strategic Shift - Yahoo Finance
Clarivate PLC (CLVT) Q3 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
Clarivate Launches New Sustainability Research Solution – Company Announcement - Financial Times
Clarivate Plc Faces Revenue Decline Amid Strategic Shift - TipRanks
RSI Alert: Clarivate (CLVT) Now Oversold - Nasdaq
Clarivate PLC (CLVT) Matches Q3 Earnings Estimates - MSN
Clarivate (CLVT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Nasdaq
Clarivate (NYSE:CLVT) Rating Lowered to "Market Perform" at William Blair - MarketBeat
From idea to invention: Clarivate granted patent from the USPTO for new text generation system - Clarivate
Clarivate shares slide over 8% as top-line misses estimates By Investing.com - Investing.com Nigeria
Clarivate shares slide over 8% as top-line misses estimates - Investing.com
Clarivate PLC Reports Q3 2024 Revenue of $622.2 Million, EPS of -$0.09, Missing Estimates - GuruFocus.com
Clarivate Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Clarivate Reports Third Quarter 2024 Results - PR Newswire
What Analyst Projections for Key Metrics Reveal About Clarivate (CLVT) Q3 Earnings - MSN
River Road Asset Management LLC Lowers Holdings in Clarivate Plc (NYSE:CLVT) - MarketBeat
IP Consulting ServicesIntellectual Property - Clarivate
Clarivate Plc (NYSE:CLVT) Given Average Rating of "Hold" by Brokerages - MarketBeat
Clarivate to Report Third Quarter 2024 Results on November 6, 20 - GuruFocus.com
Rachael Craig - Clarivate
Alexander Ishkin, PhD - Clarivate
Web of Science platform - Clarivate
Abeezer Tapia - Clarivate
People - Clarivate
The IP Management System - Clarivate
Grace Lomax - Clarivate
The Institute for Scientific Information ISI - Clarivate
Patent Cases & Litigation Trends Database - Clarivate
Cortellis Pharma Competitive Intelligence & Analytics - Clarivate
Companies to Watch: Antibody Drug Conjugates - Clarivate
Medtech Trends to Watch in 2024 - Clarivate
Biosimilars Market Insights - Clarivate
Life Sciences & Healthcare Blog & Insights - Clarivate
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):